“And with such slim margins available, how do you figure AGY will attract several hundred million dollars of investment to expand and achieve profitability, when the world's largest operator can't manage the same feat?”
As per the Albemarle slide above:
Higher prices required over next decade to support >100 new projects needed to meet demand
The current pricing is not indicative of what lies ahead. It simply does not incentivise new projects at the rate they will likely be required.
As the supply-demand balance tips, pricing increases. Economics 101.
Albemarle’s “100 new projects” comment is referring to the circa 2Mtpa of additional supply likely required in the coming decade; hence the “100” new projects, each averaging 20ktpa.
The cost curve tells us that unless many can magically reduce their costs, significantly, then pricing must rise to enable them to be built.
You know all this, and imo it is disingenuous of you to suggest/imply that AGY can’t move forward just because the big dogs are currently near break-even.
It will likely be a couple of years until our expansion is built, afaict, and then some time to get it humming along….
Iirc, an average $25k/t pricing scenario indicates circa 45% IRR for AGY’s anticipated operation.
DYOR
- Forums
- ASX - By Stock
- AGY
- Li-related News/Articles/Reports
Li-related News/Articles/Reports, page-8137
-
- There are more pages in this discussion • 797 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AGY (ASX) to my watchlist
|
|||||
Last
8.5¢ |
Change
-0.008(8.60%) |
Mkt cap ! $123.7M |
Open | High | Low | Value | Volume |
9.0¢ | 9.3¢ | 8.5¢ | $362.9K | 4.093M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 459867 | 8.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.7¢ | 93664 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 401162 | 0.085 |
4 | 219873 | 0.084 |
3 | 69062 | 0.083 |
3 | 336585 | 0.082 |
2 | 114691 | 0.081 |
Price($) | Vol. | No. |
---|---|---|
0.085 | 201 | 2 |
0.087 | 193664 | 2 |
0.088 | 232558 | 1 |
0.089 | 69615 | 2 |
0.090 | 91167 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
AGY (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online